| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $183K | — |
| R&D Expense | $452K | -58.8% |
| SG&A Expense | $2.7M | -20.9% |
| Operating Income | -$2.9M | +34.3% |
| Interest Expense | $435K | -53.0% |
| Pre-tax Income | -$3.6M | +21.6% |
| Income Tax | $0 | — |
| Net Income | -$3.6M | +21.6% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16K | -28.3% |
| Current Assets | $138K | -24.5% |
| Total Assets | $225K | -13.5% |
| Current Liabilities | $3.0M | +17.2% |
| Long-term Debt | $1.9M | -2.5% |
| Total Liabilities | $4.2M | +21.9% |
| Stockholders' Equity | -$4.0M | -24.8% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$890K | +5.8% |
| Capital Expenditures | $7K | — |
| Investing Cash Flow | -$7K | — |
| Financing Cash Flow | $890K | +5.4% |
| Free Cash Flow | -$896K | +5.1% |